Compare Dow Inc (DOW) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dow Inc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Dow Inc trades at $28.52 (market cap $20.06B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: Dow Inc is far larger — about 8.8× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Dow Inc pays a 5.04% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| DOW | SLS | |
|---|---|---|
Market Cap | $20.06B | $2.28B |
Volume | 7,817,231 | 3,128,960 |
Sector | Basic Materials | Health |
52-Week High | $41.87 | $15.46 |
52-Week Low | $20.65 | $1.39 |
Typical Hold Time | 82 Days | — |
Enterprise Value | $35.75B | $2.15B |
Dividend Yield | 5.04% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DOW trades at $28.59, up 1.53% with bearish technical signals despite recent earnings beats. The chemical company faces fundamental challenges with negative net income margin (-3.13%) and declining revenue trends from $56.9B in 2022 to $40.0B in 2025. Analyst consensus shows mixed sentiment with 30.6% buy ratings but a $34.22 price target suggesting 20% upside. Recent dividend announcement of $0.35 provides income support while cash flow trends show operational improvement projected for 2026.
DOW presents a high-risk opportunity with significant valuation disconnect - low P/S ratio (0.48) contrasts with negative profitability metrics. The stock's appeal hinges on operational turnaround and margin recovery in 2026 projections. Key risks include persistent revenue declines, high debt levels (29.87% debt-to-asset ratio), and competitive pressures in chemicals sector. Current price near support at $28 creates tactical entry point for patient investors betting on management's execution.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Dow Inc
Dow Inc is a diversified chemical manufacturing company. It combining science and technology to develop innovative solutions that are essential to human progress. Dow's portfolio is comprised of six global business units, organized into three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.
Read more on DOW →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
